Registrer deg | Logg på | FAQ      [?] 
Recent | Unread | Search | Authors | Tags | Export

mccownms hcv [31 articles]

Artikler nylig sendt til mccownms bibliotek klassifisert med nøkkelordet hcv. You can also see everyone's hcv.
  • Preclinical characteristics of the HCV NS3/4A protease inhibitor ITMN-191 (R7227)
    Antimicrob. Agents Chemother. (29 September 2008), AAC.00699-08.
    by Scott D Seiwert, Steven W Andrews, Yutong Jiang, Vladimir Serebryany, Hua Tan, Karl Kossen, Ravi PT Rajagopalan, Shawn Misialek, Sarah K Stevens, Antitsa Stoycheva, Jin Hong, Sharlene R Lim, Xiaoli Qin, Robert Rieger, Kevin R Condroski, Hailong Zhang, Mary G Do, Christine Lemieux, Gary P Hingorani, Dylan P Hartley, John A Josey, Lin Pan, Leonid Beigelman, Lawrence M Blatt
    posted to itmn-191 hcv by mccownm on 2008-09-30 16:32:57 as **
  • Telaprevir and pegylated interferon-alpha-2a inhibit wild-type and resistant genotype 1 hepatitis C virus replication in patients.
    Hepatology (Baltimore, Md.), Vol. 46, No. 3. (September 2007), pp. 631-639.
    by TL Kieffer, C Sarrazin, JS Miller, MW Welker, N Forestier, HW Reesink, AD Kwong, S Zeuzem
    posted to vx-950 resistance hcv by mccownm on 2008-09-25 23:15:43 as **
  • VX-950, a novel hepatitis C virus (HCV) NS3-4A protease inhibitor, exhibits potent antiviral activities in HCv replicon cells.
    Antimicrob Agents Chemother, Vol. 50, No. 5. (May 2006), pp. 1813-1822.
    by K Lin, RB Perni, AD Kwong, C Lin
    posted to vx-950 hcv by mccownm on 2008-09-25 23:11:42 as ** along with 1 person danielraymond
  • Hepatitis C Virus Entry Depends on Clathrin-Mediated Endocytosis
    J. Virol., Vol. 80, No. 14. (15 July 2006), pp. 6964-6972.
    by Emmanuelle Blanchard, Sandrine Belouzard, Lucie Goueslain, Takaji Wakita, Jean Dubuisson, Czeslaw Wychowski, Yves Rouille
    posted to hcv clathrin by mccownm on 2008-09-10 01:28:01 as **
  • Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion
    Gastroenterology, Vol. In Press, Uncorrected Proof
    by Anita Haberstroh, Eva K Schnober, Mirjam B Zeisel, Patric Carolla, Heidi Barth, Hubert E Blum, François-Loic Cosset, George Koutsoudakis, Ralf Bartenschlager, Ann Union, Erik Depla, Ania Owsianka, Arvind H Patel, Catherine Schuster, Françoise Stoll-Keller, Michel Doffoël, Marlène Dreux, Thomas F Baumert
    posted to entry hcv by mccownm on 2008-08-25 17:53:42 as **
  • Direct infection and replication of naturally occurring hepatitis C virus genotypes 1, 2, 3 and 4 in normal human hepatocyte cultures.
    PLoS ONE, Vol. 3, No. 7. (2008)
    by M Buck
    posted to hcv hepatocyte primary by mccownm on 2008-08-12 23:24:54 as **
  • Resistance mechanisms in HCV: from evolution to intervention
    Expert Review of Anti-Infective Therapy, Vol. 6, No. 4. (August 2008), pp. 463-478.
    by Kim, Y Arthur, Timm, Joerg
    posted to hcv resistance review by mccownm on 2008-08-05 16:47:22 as **
  • Mapping natural polymorphisms of hepatitis C virus NS3/4A protease and antiviral resistance to inhibitors in worldwide isolates.
    Antiviral therapy, Vol. 13, No. 4. (2008), pp. 481-494.
    by LL Xavier, A Moya, F Gonzàlez-Candelas
    posted to hcv protease resistance by mccownm on 2008-08-05 16:40:09 as **
  • Natural Prevalence of Hepatitis C Virus Variants with Decreased Sensitivity to NS3.4A Protease Inhibitors in Treatment-Naive Subjects.
    The Journal of infectious diseases (18 July 2008)
    by Doug J J Bartels, Yi Zhou, Eileen Z Z Zhang, Michelle Marcial, Randal A A Byrn, Thomas Pfeiffer, Ann M M Tigges, Bambang S S Adiwijaya, Chao Lin, Ann D D Kwong, Tara L L Kieffer
    posted to hcv itmn-191 vx-950 by mccownm on 2008-07-22 18:14:35 as **
  • Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Journal of viral hepatitis, Vol. 11, No. 4. (July 2004), pp. 310-318.
    by B Kronenberger, C Sarrazin, WP Hofmann, M von Wagner, E Herrmann, C Welsch, R Elez, B Rüster, A Piiper, S Zeuzem
    posted to cd81-e2 hcv by mccownm on 2008-07-17 05:12:34 as **
  • A conserved Gly436-Trp-Leu-Ala-Gly-Leu-Phe-Tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry.
    Journal of virology, Vol. 80, No. 16. (August 2006), pp. 7844-7853.
    by HE Drummer, I Boo, AL Maerz, P Poumbourios
    posted to cd81-e2 hcv by mccownm on 2008-07-17 05:10:26 as **
  • Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.
    Journal of virology, Vol. 80, No. 17. (September 2006), pp. 8695-8704.
    by AM Owsianka, JM Timms, AW Tarr, RJ Brown, TP Hickling, A Szwejk, K Bienkowska-Szewczyk, BJ Thomson, AH Patel, JK Ball
    posted to cd81-e2 hcv by mccownm on 2008-07-17 05:09:56 as **
  • Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
    Virology Journal, Vol. 5 (20 March 2008), 46.
    by Katharina B Rothwangl, Balaji Manicassamy, Susan L Uprichard, Lijun Rong
    posted to cd81-e2 hcv by mccownm on 2008-07-17 05:09:28 as **
  • Molecular basis of telapre vir resistance due to V36 and T54 mutations in the NS3-4 A protease of HCV
    Genome Biology, Vol. 9 (23 January 2008), R16.
    by Christoph Welsch, Francisco S Domingues, Simone Susser, Iris Antes, Christoph Hartmann, Gabriele Mayr, Andreas Schlicker, Christoph Sarrazin, Mario Albrecht, Stefan Zeuzem, Thomas Lengauer
    posted to hcv resistance vx-950 by mccownm on 2008-07-16 20:57:12 as ** along with 1 person antonkratz
  • Structural Modifications of Salicylates: Inhibitors of Human CD81-Receptor HCV-E2 Interaction
    Archiv der Pharmazie, Vol. 341, No. 8. (2008), pp. 478-484.
    by Marcel Holzer, Sigrid Ziegler, Alexander Neugebauer, Bernd Kronenberger, Christian D Klein, Rolf W Hartmann
    posted to antiviral cd81 hcv by mccownm on 2008-07-15 23:35:44 as **
  • Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line.
    Journal of virology, Vol. 79, No. 21. (November 2005), pp. 13778-13793.
    by MP Windisch, M Frese, A Kaul, M Trippler, V Lohmann, R Bartenschlager
    posted to hcv huh6 by mccownm on 2008-07-03 00:04:43 as **
  • High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI.
    J Biol Chem, Vol. 281, No. 27. (7 July 2006), pp. 18285-18295.
    by M Dreux, T Pietschmann, C Granier, C Voisset, S Ricard-Blum, PE Mangeot, Z Keck, S Foung, N Vu-Dac, J Dubuisson, R Bartenschlager, D Lavillette, FL Cosset
    posted to entry hcv hs by mccownm on 2008-07-02 06:07:52 as ** along with 1 person jyuh
  • Functional characterization of a fingers subdomain specific monoclonal antibodies inhibiting the hepatitis C virus RNA-dependent RNA polymerase.
    The Journal of biological chemistry (23 June 2008)
    by Andrei Nikonov, Erkki Juronen, Mart Ustav
    posted to hcv ns5b s96t by mccownm on 2008-07-01 16:05:01 as **
  • R1626 plus peginterferon Alfa-2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin.
    Hepatology (Baltimore, Md.) (20 June 2008)
    by Paul J J Pockros, David Nelson, Eliot Godofsky, Maribel Rodriguez-Torres, Gregory T T Everson, Michael W W Fried, Reem Ghalib, Stephen Harrison, Lisa Nyberg, Mitchell L L Shiffman, Isabel Najera, Anna Chan, George Hill
    posted to hcv r1626 by mccownm on 2008-06-30 16:41:06 as **
  • Protein Kinase A dependent step(s) in Hepatitis C virus entry and infectivity.
    Journal of virology (25 June 2008)
    by Michelle J J Farquhar, Helen J J Harris, Mandy Diskar, Sarah Jones, Christopher J J Mee, Soren U U Nielsen, Claire L L Brimacombe, Sonia Molina, Geoffrey L L Toms, Patrick Maurel, John Howl, Friedrich W W Herberg, Sven C D C van Ijzendoorn, Peter Balfe, Jane A A McKeating
    posted to entry hcv by mccownm on 2008-06-30 16:39:07 as **
  • A transient cell-based phenotype assay for hepatitis C NS3/4A protease: Application to potency determinations of a novel macrocyclic inhibitor against diverse protease sequences isolated from plasma infected with HCV.
    Journal of virological methods (24 June 2008)
    by Steven W W Ludmerer, Donald J J Graham, Mihir Patel, Kevin Gilbert, Mark Stahlhut, David B B Olsen
    posted to hcv protease by mccownm on 2008-06-30 16:38:18 as **
  • Intramembrane Processing by Signal Peptide Peptidase Regulates the Membrane Localization of Hepatitis C Virus Core Protein and Viral Propagation
    J. Virol. (18 June 2008), JVI.00306-08.
    by Kiyoko Okamoto, Yoshio Mori, Yasumasa Komoda, Toru Okamoto, Masayasu Okochi, Masatoshi Takeda, Tetsuro Suzuki, Kohji Moriishi, Yoshiharu Matsuura
    posted to hcv spp by mccownm on 2008-06-20 00:50:23 as **
  • Identification of Terfenadine as an Inhibitor of Human CD81-Receptor HCV-E2 Interaction: Synthesis and Structure Optimization.
    Molecules (Basel, Switzerland), Vol. 13, No. 5. (2008), pp. 1081-1110.
    by M Holzer, S Ziegler, B Albrecht, B Kronenberger, A Kaul, R Bartenschlager, L Kattner, CD Klein, RW Hartmann
    posted to entry hcv by mccownm on 2008-06-19 19:58:30 as **
  • Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin.
    Hepatology (Baltimore, Md.), Vol. 47, No. 5. (May 2008), pp. 1437-1445.
    by Y Nahmias, J Goldwasser, M Casali, D van Poll, T Wakita, RT Chung, ML Yarmush
    posted to assembly hcv naringenin by mccownm on 2008-06-18 19:30:47 as ** along with 1 person jyuh
  • Regulation of hepatitis C virion production via phosphorylation of the NS5A protein.
    PLoS pathogens, Vol. 4, No. 3. (March 2008)
    by TL Tellinghuisen, KL Foss, J Treadaway
    posted to assembly hcv ns5a by mccownm on 2008-06-18 18:59:38 as **
  • MOLECULAR MECHANISM OF HEAPTITIS C VIRUS REPLICON VARIANTS WITH REDUCED SUSCEPTIBILITY TO A BENZOFURAN INHIBITOR, HCV-796
    Antimicrob. Agents Chemother. (16 June 2008), AAC.00238-08.
    by Anita Y Howe, Huiming Cheng, Stephen Johann, Stanley Mullen, Srinivas K Chunduru, Dorothy C Young, Joel Bard, Rajiv Chopra, Girija Krishnamurthy, Tarek Mansour, John O'Connell
    posted to hcv hcv-796 resistance by mccownm on 2008-06-17 15:47:02 as **
  • Hepatitis C virus budding at lipid droplet-associated ER membrane visualized by 3D electron microscopy.
    Histochemistry and cell biology (30 May 2008)
    by Philippe Roingeard, Christophe Hourioux, Emmanuelle Blanchard, Gérard Prensier
    posted to droplet hcv by mccownm on 2008-05-31 21:23:42 as **
  • The emerging field of HCV drug resistance
    Expert Opinion on Investigational Drugs, Vol. 17, No. 3. (March 2008), pp. 303-319.
    by Koev, Gennadiy, Kati, Warren
    posted to hcv resistance review by mccownm on 2008-05-31 21:16:41 as **
  • In vitro studies of cross-resistance mutations against two hepatitis C virus serine protease inhibitors, VX-950 and BILN 2061.
    The Journal of biological chemistry, Vol. 280, No. 44. (4 November 2005), pp. 36784-36791.
    by C Lin, CA Gates, BG Rao, DL Brennan, JR Fulghum, YP Luong, JD Frantz, K Lin, S Ma, YY Wei, RB Perni, AD Kwong
    posted to bi-2061 hcv vx-950 by mccownm on 2008-05-27 21:50:14 as **
  • Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir.
    Gastroenterology, Vol. 132, No. 5. (May 2007), pp. 1767-1777.
    by C Sarrazin, TL Kieffer, D Bartels, B Hanzelka, U Müh, M Welker, D Wincheringer, Y Zhou, HM Chu, C Lin, C Weegink, H Reesink, S Zeuzem, AD Kwong
    posted to hcv vx-950 by mccownm on 2008-05-27 21:49:39 as **
  • Hepatitis C Virus Core Protein Induces Lipid Droplet Redistribution in a Microtubule- and Dynein-Dependent Manner.
    Traffic (Copenhagen, Denmark) (16 May 2008)
    by Steeve Boulant, Mark W W Douglas, Laura Moody, Agata Budkowska, Paul Targett-Adams, John McLauchlan
    posted to droplet hcv lipid by mccownm on 2008-05-26 22:23:58 as **
    • NB: Du kan sitere denne siden som: http://www.citeulike.org/user/mccownm/tag/hcv

    RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.